Miramar Capital LLC Acquires New Position in Humana Inc (HUM)

Miramar Capital LLC acquired a new stake in shares of Humana Inc (NYSE:HUM) during the 4th quarter, HoldingsChannel reports. The fund acquired 800 shares of the insurance provider’s stock, valued at approximately $237,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Moody National Bank Trust Division bought a new position in shares of Humana during the fourth quarter valued at approximately $30,000. We Are One Seven LLC bought a new position in shares of Humana during the fourth quarter valued at approximately $31,000. Proficio Capital Partners LLC grew its holdings in shares of Humana by 81.4% during the fourth quarter. Proficio Capital Partners LLC now owns 107 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 48 shares during the last quarter. Exane Asset Management bought a new position in shares of Humana during the fourth quarter valued at approximately $43,000. Finally, Sontag Advisory LLC bought a new position in shares of Humana during the fourth quarter valued at approximately $47,000. Hedge funds and other institutional investors own 93.28% of the company’s stock.

Several equities analysts have recently commented on the company. Zacks Investment Research lowered Humana from a “buy” rating to a “hold” rating in a report on Friday, February 8th. Citigroup lowered their target price on Humana from $397.00 to $362.00 and set a “buy” rating for the company in a report on Thursday, February 7th. Credit Suisse Group lowered their target price on Humana from $390.00 to $352.00 and set an “outperform” rating for the company in a report on Thursday, February 7th. Stephens assumed coverage on Humana in a report on Monday, January 14th. They set an “overweight” rating and a $336.00 target price for the company. Finally, Cowen raised Humana from a “market perform” rating to an “outperform” rating and set a $275.02 target price for the company in a report on Friday, January 11th. Five research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $355.06.

In other news, insider Christopher H. Hunter sold 15,586 shares of the stock in a transaction on Monday, February 25th. The stock was sold at an average price of $305.24, for a total transaction of $4,757,470.64. Following the completion of the sale, the insider now owns 28,100 shares in the company, valued at approximately $8,577,244. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Roy A. Beveridge sold 8,278 shares of the stock in a transaction on Tuesday, February 19th. The shares were sold at an average price of $307.16, for a total value of $2,542,670.48. Following the sale, the insider now owns 12,409 shares of the company’s stock, valued at approximately $3,811,548.44. The disclosure for this sale can be found here. 0.54% of the stock is currently owned by corporate insiders.

HUM opened at $283.45 on Wednesday. The company has a market capitalization of $38.27 billion, a price-to-earnings ratio of 19.48, a PEG ratio of 1.16 and a beta of 0.94. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.68 and a quick ratio of 1.68. Humana Inc has a 1-year low of $261.35 and a 1-year high of $355.88.

Humana (NYSE:HUM) last released its earnings results on Wednesday, February 6th. The insurance provider reported $2.65 earnings per share for the quarter, topping analysts’ consensus estimates of $2.53 by $0.12. The firm had revenue of $14.17 billion during the quarter, compared to the consensus estimate of $14.04 billion. Humana had a return on equity of 19.64% and a net margin of 2.96%. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.06 earnings per share. On average, analysts predict that Humana Inc will post 17.49 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be given a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date of this dividend is Thursday, March 28th. This is an increase from Humana’s previous quarterly dividend of $0.50. Humana’s dividend payout ratio is 6.87%.

TRADEMARK VIOLATION WARNING: “Miramar Capital LLC Acquires New Position in Humana Inc (HUM)” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be read at https://www.dispatchtribunal.com/2019/03/20/miramar-capital-llc-acquires-new-position-in-humana-inc-hum.html.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Further Reading: How do taxes affect a CDs total return?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.